Lifeboat Foundation

Intel Corp. Chief Executive Officer Pat Gelsinger, plotting a comeback for the once-dominant chipmaker, made the case that the company’s technology will be vital to an industrywide boom in artificial intelligence computing.

Speaking at Intel’s annual Innovation conference, Gelsinger pointed to advances that his company is making in production technology and software developer tools for AI. The opportunity will only grow as more artificial intelligence capabilities are powered by personal computers, he said.

“AI represents a generational shift, giving rise to a new era of global expansion where computing is even more foundational to a better future for all,” Gelsinger said. “For developers, this creates massive societal and business opportunities to push the boundaries of what’s possible, to create solutions to the world’s biggest challenges.”

Synthetic fertilizers, one the most important developments in modern agriculture, have enabled many countries to secure a stable food supply. Among them, organic ureas (or organoureas) have become prominent sources of nitrogen for crops. Since these compounds do not dissolve immediately in water, but instead are slowly decomposed by soil microorganisms, they provide a stable and controlled supply of nitrogen, which is crucial for plant growth and function.

However, traditional methods to synthesize organoureas are environmentally harmful due to their use of toxic substances, such as phosgene. Although alternative synthesis strategies have been demonstrated, these either rely on expensive and scarce noble metals or employ catalysts that cannot be reused easily.

In a recent effort to address these challenges, a research team including Honorary Professor Hideo Hosono from Tokyo Institute of Technology, Japan, has leveraged the quantum properties of bismuth selenide (Bi₂Se₃) to synthesize organoureas. Their study is published in Science Advances.

Amazon is looking to position itself as the one-stop shop for AI. The e-commerce giant designs its own chips for training huge AI models. Through Amazon Bedrock customers can also design their own generative AI applications using existing models, which are all run on the Amazon cloud. The company sells its own AI applications too.

Anthropic already counts some high-profile backers, including Google and Salesforce Ventures. This support comes as tech giants continue to make massive bets on AI companies, a move sparked by Microsoft’s multi-billion dollar investment in ChatGPT maker OpenAI in January.

OpenAI’s ChatGPT can now “see, hear and speak,” or, at least, understand spoken words, respond with a synthetic voice and process images, the company announced Monday.

The update to the chatbot — OpenAI’s biggest since the introduction of GPT-4 — allows users to opt into voice conversations on ChatGPT’s mobile app and choose from five different synthetic voices for the bot to respond with. Users will also be able to share images with ChatGPT and highlight areas of focus or analysis (think: “What kinds of clouds are these?”).

Continue reading “ChatGPT can now ‘speak,’ listen and process images, OpenAI says” »

When the spinal cords of mice and humans are partially damaged, the initial paralysis is followed by the extensive, spontaneous recovery of motor function. However, after a complete spinal cord injury, this natural repair of the spinal cord doesn’t occur and there is no recovery. Meaningful recovery after severe injuries requires strategies that promote the regeneration of nerve fibers, but the requisite conditions for these strategies to successfully restore motor function have remained elusive.

“Five years ago, we demonstrated that nerve fibers can be regenerated across anatomically complete spinal cord injuries,” says Mark Anderson, a senior author of the study. “But we also realized this wasn’t enough to restore motor function, as the new fibers failed to connect to the right places on the other side of the lesion.” Anderson is the director of Central Nervous System Regeneration at. NeuroRestore and a scientist at the Wyss Center for Bio and Neuroengineering.

Continue reading “Regeneration across complete spinal cord injuries reverses paralysis” »

A. There are so many mundane but essential administrative and clerical tasks that clog up a clinician’s workday. A computer screen is actively competing for our attention. It’s the part of the industry we – as physicians – were never trained for. But, years of “we’ve always done it that way” created this anchor on us all, leading to burnout and driving thousands out of the industry during the pandemic.

Processes vastly simplified and improved by generative AI can be a powerful recruitment tool to bring a new generation into the healthcare industry and patient care without arcane and difficult processes in their way. By eliminating needless note-taking and long nights of billing and coding for reimbursement purposes, doctors can get back to solving the real issues of patient care.

Sandman, a new cyber threat actor, is targeting telecom providers across continents.

The recent introduction of the breathtaking AI tool ChatGPT has sparked a national dialogue about the future of artificial intelligence in health care, education, research, and beyond. In this session, four UCSF experts discuss AI’s current and potential uses, in areas ranging from research to education to clinical care. After a brief presentation by each speaker, DOM Chair Bob Wachter moderates a far-ranging panel discussion on the health care applications of ChatGPT.

Speakers:
Atul Butte, MD, PhD, professor of Pediatrics, Bioengineering and Therapeutic Sciences, and Epidemiology and Biostatistics; director, UCSF Bakar Computational Health Sciences Institute; chief data scientist, University of California Health System.

Continue reading “ChatGPT: Will It Transform the World of Health Care?” »

The blood cancer treatment venetoclax (Venclexta; Roche, Genentech, AbbVie) was found to kill latent HIV-infected cells, indicating a possible new treatment for the virus, according to the results of a preclinical study by the Walter and Eliza Hall Institute and The Peter Doherty Institute for Infection and Immunity.

When HIV-infected cells are latent, the virus remains in the body and is untreatable by therapies currently on the market, which is why patients with HIV must stay on treatment to suppress the virus. Currently, antiretroviral therapies (ART) are the standard of care treatment for patients with HIV, however, they cannot target latent infection.

Although antiretroviral therapies are the standard of care treatment for those with HIV, the drugs cannot target latent infections; however, venetoclax, a blood cancer treatment, shows promise.

Continue reading “Study: Blood Cancer Treatment Found to Kill Latent HIV-Infected Cells, Possible New Treatment” »